Concord Biotech Ltd IPO
Price Range
₹705 - ₹741
-
Min. Quantity
20 Shares
Closes on
8 August 2023
-
Min. investment
₹14,820
Concord Biotech Ltd IPO Timeline
| Event | Date |
|---|---|
| Concord Biotech Ltd IPO Opening Date | 4 August 2023 |
| Concord Biotech Ltd IPO Closing Date | 8 August 2023 |
| Basis of Allotment | 11 August 2023 |
| Initiation of Refunds | 14 August 2023 |
| Credit of Shares to Demat | 17 August 2023 |
| Concord Biotech Ltd IPO Listing Date | 18 August 2023 |
Concord Biotech Ltd IPO Details
| Concord Biotech Ltd IPO Date | 4 August 2023 to 8 August 2023 |
| Concord Biotech Ltd IPO Face Value | ₹1 per share |
| Concord Biotech Ltd IPO Price | ₹705 to ₹741 per share |
| Concord Biotech Ltd IPO Lot Size | 20 |
| Issue Size | Shares of ₹1 (aggregating up to ₹1,550.52 Cr) |
| Fresh Issue | Shares of ₹1 (aggregating up to ₹0 Cr) |
| Offer for Sale | Shares of ₹1 (aggregating up to ₹1,475.26 Cr) |
| Issue Type | (Book Built Portion) |
| Listing At | BSE, NSE |
| QIB Shares Offered | Not more than 41,83,130 of the Net Offer |
| Retail Shares Offered | Not less than 73,20,479 of the Net Offer |
| NII (HNI) Shares Offered | Not less than 31,37,348 of the Net Offer |
| Company Promoters | Sudhir Vaid, Ankur Vaid |
Concord Biotech Ltd IPO Lot Size
The Concord Biotech Ltd IPO lot size is 20 shares. A retail-individual investor can apply for up to 13 lots (260 shares or ₹1,92,660).
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Minimum | 1 | 20 | ₹14,820 |
| Maximum | 13 | 260 | ₹1,92,660 |
- Strengths
- Risks
- Opportunities
- Established presence across the complex fermentation value chain;
- Global leadership in immunosuppressant APIs along with a wide spectrum of complex fermentation-based APIs across multiple therapeutic areas;
- Scaled manufacturing facilities with a consistent regulatory compliance track record and supported by strong R&D capabilities;
- Diversified global customer base with long-standing relationships with key customers;
- Experienced Promoters, management team supported by marquee investors;
- Financial track record of rapid growth and consistent profitability with healthy cash flows and shareholder returns.
Company Financials
Concord Biotech Ltd Financial Information (Restated)
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 03-2025 | 2,034.18 | 1,244.53 | 372.96 |
| 03-2024 | 1,699.32 | 1,050.72 | 304.73 |
| 03-2023 | 1,514.65 | 888.48 | 238.13 |
| Amount in ₹ Crore | |||
Objects of the Issue
The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
- Listing the Equity Shares on the Stock Exchanges
Concord Biotech Ltd IPO Promoter Holding
| Pre Issue Share Holding | 28.84% |
| Post Issue Share Holding | 28.84% |
Concord Biotech Ltd IPO Subscription Status (Bidding Detail)
The Concord Biotech Ltd IPO is subscribed 24.87 times on 8 August 2023 05:00:00 PM. The public issue subscribed 3.78 times in the retail category, 67.67 times in the QIB category, and 16.99 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | QIB | NII | Retail | Employee | Total |
| Subscription (times) | 67.67 | 16.99 | 3.78 | 24.48 | 24.87 |
Concord Biotech Ltd IPO Prospectus
Concord Biotech Ltd IPO Listing Date
| BSE Script | |
| NSE Symbol | |
| Listing In | BSE, NSE |
| ISIN | INE338H01029 |
| IPO Price | ₹- |
| Face Value | ₹- |
Company Contact Information
1482-86 Trasad RoadDholka,Ahmedabad-382225
Phone: 91-079-68138700
Email: complianceofficer@concordbiotech.com
Website: www.concordbiotech.com
Concord Biotech Ltd IPO Registrar
Concord Biotech Ltd IPO Lead Manager(s)
- Kotak Mahindra Capital Company Ltd
- Citigroup Global Markets India Pvt Ltd
- Jeffries India Pvt Ltd
How to Check the Allotment Status of Concord Biotech Ltd IPO?
To check the IPO allotment status, follow these steps:
- Visit the official website of the IPO registrar.
- Navigate to the IPO Allotment Status page.
- Select “Concord Biotech Ltd” from the list of available IPOs.
- Enter any one of these - PAN Number, Application Number, DP/Client ID.
- Click on Submit to view your allotment status.
About Concord Biotech Ltd IPO
Concord Biotech Limited was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies. Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC.